Literature DB >> 10740155

Alcohol consumption and plasminogen activator inhibitor type 1: the National Heart, Lung, and Blood Institute Family Heart Study.

L Djoussé1, J S Pankow, D K Arnett, Y Zhang, Y Hong, M A Province, R C Ellison.   

Abstract

BACKGROUND: Plasminogen activator inhibitor type 1 (PAI-1) plays a key role in fibrinolytic activity, which is important for thrombotic cardiovascular events. It has been suggested that moderate alcohol consumption may protect against coronary heart disease and ischemic stroke. However, little is known about the effects of moderate doses of alcohol on PAI-1. METHODS AND
RESULTS: We assessed the association between different levels of alcohol consumption and PAI-1 among 1862 participants of the National Heart, Lung, and Blood Institute Family Heart Study. We fitted a regression model, adjusting for anthropometric, metabolic, and lifestyle factors. Individuals in the highest alcohol intake category were leaner, had higher high-density lipoprotein cholesterol levels, smoked more cigarettes, and consumed less dietary fiber compared with never-drinkers. For drinking categories of never-drinkers, ex-drinkers, and current drinkers of 0.1 to 1.4, 1.5 to 4.9, 5.0 to 14.9, and > or =15 g/d of alcohol, multivariate adjusted geometric mean PAI-1 levels among women were 10.77, 9.41, 9.99, 11.21, 11.28, and 16.40 ng/mL, respectively. With similar categories except the top category divided into 15.0 to 29.9 and > or =30 g/d, PAI-1 levels among men were 18.43, 15.77, 15.19, 16.20, 17.27, 24.02, and 29.46 ng/mL, respectively.
CONCLUSIONS: These results show that alcohol consumption up to 14.9 g/d is not associated with increased PAI-1, whereas the findings suggest increased PAI-1 with greater alcohol intake.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10740155     DOI: 10.1016/s0002-8703(00)90052-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  Redefining postinjury fibrinolysis phenotypes using two viscoelastic assays.

Authors:  Gregory R Stettler; Ernest E Moore; Hunter B Moore; Geoffrey R Nunns; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2019-04       Impact factor: 3.313

2.  Binge ethanol intake in chronically exposed rat liver decreases LDL-receptor and increases angiotensinogen gene expression.

Authors:  Annayya R Aroor; Shivendra D Shukla
Journal:  World J Hepatol       Date:  2011-09-27

3.  Moderate wine consumption is associated with lower hemostatic and inflammatory risk factors over 8 years: The study of women's health across the nation (SWAN).

Authors:  Imke Janssen; Alan L Landay; Kristine Ruppert; Lynda H Powell
Journal:  Nutr Aging (Amst)       Date:  2014-06-12

4.  Relationships of PAI-1 levels to central obesity and liver steatosis in a sample of adult male population in southern Italy.

Authors:  Antonio Barbato; Roberto Iacone; Giovanni Tarantino; Ornella Russo; Paolo Sorrentino; Sonia Avallone; Ferruccio Galletti; Eduardo Farinaro; Elisabetta Della Valle; Pasquale Strazzullo
Journal:  Intern Emerg Med       Date:  2009-04-07       Impact factor: 3.397

5.  Wine consumption reduced postprandial platelet sensitivity against platelet activating factor in healthy men.

Authors:  Marianna N Xanthopoulou; Konstantia Kalathara; Sophia Melachroinou; Kalliopi Arampatzi-Menenakou; Smaragdi Antonopoulou; Mary Yannakoulia; Elizabeth Fragopoulou
Journal:  Eur J Nutr       Date:  2016-03-02       Impact factor: 5.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.